The risk of blood clots after COVID-19 vaccinations is very low finds a new study of 46-million adults in England. The research, which involved University of Bristol academics, showed that people vaccinated with Oxford-AstraZeneca or Pfizer-BioNTech had a lower risk of all venous clots (such as deep vein thrombosis and pulmonary embolism) and all arterial clots (such as strokes and heart attacks), particularly in people over 70 years.
COVID-19: Risk of blood clot increases for up to six months after having virus study finds, UK News
Blood thinners being used to mitigate risk of clots in COVID-19 patients - CBS News
Long COVID scientists try to unravel blood clot mystery, The Transmission
Death From Blood Clot in Australia Linked to AstraZeneca Coronavirus Vaccine
The AstraZeneca Vaccine Blood-Clot Issue Won't Go Away - The Atlantic
COVID: Blood clot risks still higher a year after infection, study says
MHRA issues new advice, concluding a possible link between COVID-19 Vaccine AstraZeneca and extremely rare, unlikely to occur blood clots
Increased risk of blood clots in covid patients with specific gene variant - SciLifeLab
Autoantibodies and neutrophils may be cause of COVID-19 blood clots
Blood Clot Awareness Month 2018: “Raise Your Voice to Raise Blood Clot Awareness” - Blood Clots
Ireland temporarily suspends use of AstraZeneca vaccine, Coronavirus pandemic News
COVID-19's high blood clot risk
Study finds increased risk of blood clots up to six months after COVID-19
Fact check: No link between Air Force cadet's death, COVID-19 vaccine